NO304428B1 - AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler - Google Patents
AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazolerInfo
- Publication number
- NO304428B1 NO304428B1 NO932044A NO932044A NO304428B1 NO 304428 B1 NO304428 B1 NO 304428B1 NO 932044 A NO932044 A NO 932044A NO 932044 A NO932044 A NO 932044A NO 304428 B1 NO304428 B1 NO 304428B1
- Authority
- NO
- Norway
- Prior art keywords
- vinylazoles
- preparation
- therapeutically active
- analogous procedure
- analogous
- Prior art date
Links
- MZNSQRLUUXWLSB-UHFFFAOYSA-N 2-ethenyl-1h-pyrrole Chemical class C=CC1=CC=CN1 MZNSQRLUUXWLSB-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4039559A DE4039559A1 (de) | 1990-12-07 | 1990-12-07 | Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln |
| PCT/EP1991/002359 WO1992010482A1 (de) | 1990-12-07 | 1991-12-09 | Funktionalisierte vinylazole enthaltende pharmazeutische präparate, verwendung dieser vinylazole zur herstellung von arzneimitteln, vinylazole selbst sowie verfahren zu deren herstellung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO932044D0 NO932044D0 (no) | 1993-06-04 |
| NO932044L NO932044L (no) | 1993-06-04 |
| NO304428B1 true NO304428B1 (no) | 1998-12-14 |
Family
ID=6420083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO932044A NO304428B1 (no) | 1990-12-07 | 1993-06-04 | AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5344834A (no) |
| EP (1) | EP0550697A1 (no) |
| JP (1) | JPH06503818A (no) |
| KR (1) | KR930703263A (no) |
| CN (1) | CN1064863A (no) |
| AU (1) | AU660296B2 (no) |
| CA (1) | CA2097824C (no) |
| CS (1) | CS369691A3 (no) |
| DE (1) | DE4039559A1 (no) |
| FI (1) | FI932572A (no) |
| HU (1) | HUT64036A (no) |
| IE (1) | IE914259A1 (no) |
| IL (1) | IL100274A (no) |
| NO (1) | NO304428B1 (no) |
| PT (1) | PT99714B (no) |
| WO (1) | WO1992010482A1 (no) |
| ZA (1) | ZA919662B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5418250A (en) * | 1989-06-14 | 1995-05-23 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
| GB2273704B (en) * | 1992-12-16 | 1997-01-22 | Orion Yhtymae Oy | Triazolyl diaryl selective aromatase inhibiting compounds |
| US5395847A (en) * | 1993-12-02 | 1995-03-07 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids |
| US20020086856A1 (en) | 1998-03-18 | 2002-07-04 | Alfred Schmidt | Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| EP0943333A1 (de) * | 1998-03-18 | 1999-09-22 | S.W. Patentverwertungs GmbH | Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen |
| CN100358866C (zh) * | 2004-04-08 | 2008-01-02 | 上海交通大学 | 含对强碱不稳定取代基的n-乙烯基取代吡咯的制备方法 |
| JP6470984B2 (ja) * | 2015-01-27 | 2019-02-13 | 学校法人東日本学園 | アロマターゼ阻害剤及びこれを含む医薬 |
| CN105732977B (zh) * | 2016-01-30 | 2018-03-02 | 宝鸡文理学院 | 一种可溶性聚苯并二噻唑‑酰胺荧光聚合物及其制备方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1580535A (en) * | 1976-08-27 | 1980-12-03 | Ici Ltd | Substituted ketones and their use as herbicides |
| EP0003884A3 (en) * | 1978-02-23 | 1979-09-19 | Imperial Chemical Industries Plc | Alpha-beta unsaturated ketone derivatives useful as herbicides |
| DE2826760A1 (de) * | 1978-06-19 | 1980-01-03 | Hoechst Ag | Derivate des 1,2,4-triazols |
| JPS62149666A (ja) * | 1985-12-25 | 1987-07-03 | Shionogi & Co Ltd | Ｎ−ビニルアゾ−ル類 |
| US4749713A (en) * | 1986-03-07 | 1988-06-07 | Ciba-Geigy Corporation | Alpha-heterocycle substituted tolunitriles |
| GB8716650D0 (en) * | 1987-07-15 | 1987-08-19 | Ici Plc | Use of olefinic compounds |
-
1990
- 1990-12-07 DE DE4039559A patent/DE4039559A1/de not_active Withdrawn
-
1991
- 1991-12-05 CS CS913696A patent/CS369691A3/cs unknown
- 1991-12-06 CN CN91112779A patent/CN1064863A/zh active Pending
- 1991-12-06 ZA ZA919662A patent/ZA919662B/xx unknown
- 1991-12-06 PT PT99714A patent/PT99714B/pt not_active IP Right Cessation
- 1991-12-08 IL IL10027491A patent/IL100274A/en not_active IP Right Cessation
- 1991-12-09 US US07/802,639 patent/US5344834A/en not_active Expired - Fee Related
- 1991-12-09 CA CA002097824A patent/CA2097824C/en not_active Expired - Fee Related
- 1991-12-09 EP EP19920900266 patent/EP0550697A1/de not_active Withdrawn
- 1991-12-09 JP JP4500378A patent/JPH06503818A/ja active Pending
- 1991-12-09 AU AU90454/91A patent/AU660296B2/en not_active Ceased
- 1991-12-09 WO PCT/EP1991/002359 patent/WO1992010482A1/de not_active Application Discontinuation
- 1991-12-09 HU HU931657A patent/HUT64036A/hu unknown
- 1991-12-09 IE IE425991A patent/IE914259A1/en unknown
- 1991-12-09 KR KR1019930701698A patent/KR930703263A/ko not_active Application Discontinuation
-
1993
- 1993-06-04 FI FI932572A patent/FI932572A/fi unknown
- 1993-06-04 NO NO932044A patent/NO304428B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO932044D0 (no) | 1993-06-04 |
| HUT64036A (en) | 1993-11-29 |
| JPH06503818A (ja) | 1994-04-28 |
| IL100274A (en) | 1996-08-04 |
| DE4039559A1 (de) | 1992-06-11 |
| AU9045491A (en) | 1992-07-08 |
| FI932572A0 (fi) | 1993-06-04 |
| IE914259A1 (en) | 1992-06-17 |
| FI932572A (fi) | 1993-06-04 |
| KR930703263A (ko) | 1993-11-29 |
| ZA919662B (en) | 1992-09-30 |
| HU9301657D0 (en) | 1993-09-28 |
| AU660296B2 (en) | 1995-06-22 |
| EP0550697A1 (de) | 1993-07-14 |
| CN1064863A (zh) | 1992-09-30 |
| PT99714B (pt) | 1999-05-31 |
| CS369691A3 (en) | 1992-06-17 |
| WO1992010482A1 (de) | 1992-06-25 |
| NO932044L (no) | 1993-06-04 |
| CA2097824A1 (en) | 1992-06-08 |
| CA2097824C (en) | 2003-04-08 |
| US5344834A (en) | 1994-09-06 |
| PT99714A (pt) | 1992-10-30 |
| IL100274A0 (en) | 1992-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| NO179448C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser | |
| NO914667D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater | |
| NO914825D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme alfa-oxoacetamider | |
| NO179283C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler | |
| NO176796C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater | |
| NO180586C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler | |
| NO914036D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater | |
| NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
| NO894842D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazoler. | |
| NO178619C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler | |
| NO900032D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser. | |
| NO176275C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater | |
| NO903941D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater. | |
| NO175528C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater | |
| NO175714C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, aromatiske estere | |
| NO173784C (no) | Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater | |
| NO912797L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme karbostirilderivater. | |
| NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
| NO174774C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner | |
| NO914071D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser | |
| NO304428B1 (no) | AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler | |
| NO173606C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater | |
| NO894949L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzopyranylpyrrolinonderivater. | |
| NO904800D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karbamater. |